Publikationen (47) Publikationen von RAFAEL ENRÍQUEZ DE SALAMANCA LORENTE

2023

  1. Diagnosis, evaluation and monitoring of acute hepatic porphyria

    Medicina Clinica

  2. Understanding Carbohydrate Metabolism and Insulin Resistance in Acute Intermittent Porphyria

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

2021

  1. Acute intermittent porphyria, givosiran, and homocysteine

    Journal of Inherited Metabolic Disease

2017

  1. Prognostic models for locally advanced cervical cancer: External validation of the published models

    Journal of Gynecologic Oncology, Vol. 28, Núm. 5

2015

  1. Vitamin D-binding protein as a biomarker of active disease in acute intermittent porphyria

    Journal of Proteomics, Vol. 127, pp. 377-385

2014

  1. A novel mutation in the SLC40A1 gene associated with reduced iron export in vitro

    American Journal of Hematology, Vol. 89, Núm. 7, pp. 689-694

2013

  1. Familial porphyria cutanea tarda in Spain: Characterization of eight novel mutations in the UROD gene and haplotype analysis of the common p.G281E mutation

    Gene, Vol. 522, Núm. 1, pp. 89-95

  2. Functional associations of genetic variants involved in the clinical manifestation of erythropoietic protoporphyria in the Argentinean population

    Journal of the European Academy of Dermatology and Venereology, Vol. 27, Núm. 6, pp. 754-762

2012

  1. Molecular analysis of the UROD gene in 17 Argentinean patients with familial porphyria cutanea tarda: Characterization of four novel mutations

    Molecular Genetics and Metabolism, Vol. 105, Núm. 4, pp. 629-633

  2. Mutations in the HFE, TFR2, and SLC40A1 genes in patients with hemochromatosis

    Gene, Vol. 508, Núm. 1, pp. 15-20

  3. Porfirias agudas en la unidad de cuidados intensivos

    Emergencias

  4. Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates.

    Journal of translational medicine, Vol. 10, pp. 122

2011

  1. Porfiriaconscientes

    Más dermatología, Núm. 15, pp. 2-3

  2. Tumour VEGF/Non Tumour VEGF protein expression ratio as a biomarker for survival in colorectal cancer patients

    European Journal of Surgical Oncology, Vol. 37, Núm. 6, pp. 526-531

  3. Two novel mutations in the SLC40A1 and HFE genes implicated in iron overload in a Spanish man

    European Journal of Haematology, Vol. 86, Núm. 3, pp. 260-264

2010

  1. Hepcidin treatment in Hfe-/- mice diminishes plasma iron without affecting erythropoiesis

    European Journal of Clinical Investigation, Vol. 40, Núm. 6, pp. 511-517

2009

  1. Epidermal growth factor receptor ligands in murine models for erythropoietic protoporphyria: Potential novel players in the progression of liver injury

    Cellular and Molecular Biology, Vol. 55, Núm. 1, pp. 29-37

  2. Identification and characterization of HMBS gene mutations in Spanish patients with acute intermittent porphyria

    Cellular and Molecular Biology, Vol. 55, Núm. 2, pp. 55-63

  3. In vivo effect an luteinizing hormone-releasing hormone analog on vascular endothelial growth factor and epidermal growth factor receptor expression in mammary tumors

    Journal of Carcinogenesis, Vol. 8

  4. Induction of hepatic aminolevulinate acid synthetase activity by isoflurane in a genetic model for erythropoietic protoporphyria

    Cellular and Molecular Biology, Vol. 55, Núm. 1, pp. 38-44